Atticus Pharma
PrivateLast Round
Grant
Nov 4, 2025
Total Funding Raised
$2.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atticus Pharma operates in Healthcare & Life Sciences and is based in Greenville, South Carolina. Its latest recorded funding round was a Grant round in November 2025.
Atticus Pharma is a biopharmaceutical company that develops topical therapeutics for immunodermatology and associated conditions using its proprietary Z-pod sustained-release drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atticus Pharma Comparables
Compare Atticus Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermaliq Therapeutics, Inc. | 83% | |
| Triple Hair Group Inc. | 78% | |
| Eirion Therapeutics | 78% |
For institutional investors. Book with your work email.
Atticus Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 4, 2025 | ||||
| Convertible Debt | Sep 1, 2024 |
For institutional investors. Book with your work email.
Atticus Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Activation Capital | Convertible Debt |
| gener8tor | Convertible Debt |
| SC Launch | Convertible Debt |
| Endless Frontier Labs | Convertible Debt |
| SCRA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 55% MoM.
- May 21, 2026
Monthly visitors increased 311% to 1,004.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 25, 2026
On Aug 25th '26, Atticus Pharma Inc. receives a Notice of Award for a $2M Phase II Small Business Innovation Research grant from the NIH's National Institute of Diabetes and Digestive and Kidney Diseases in California to optimize a topical erectile dysfunction treatment.
For institutional investors. Book with your work email.
Atticus Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atticus Pharma's valuation, stock price, and market status.
Is Atticus Pharma a public or private company?
Atticus Pharma is a private company.
What is the current stock price of Atticus Pharma?
Atticus Pharma is a private company, so its shares have no public market price. Caplight tracks Atticus Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atticus Pharma worth (valuation)?
Valuation information for Atticus Pharma is not publicly available.
Can I buy Atticus Pharma stock?
Atticus Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atticus Pharma's last funding round?
Atticus Pharma's most recent funding round was Grant on November 4, 2025.
Who are the main investors in Atticus Pharma?
Key investors in Atticus Pharma include Activation Capital, gener8tor, SC Launch, Endless Frontier Labs, SCRA.
Will Atticus Pharma IPO soon?
No public IPO plans have been announced for Atticus Pharma.
How can I track Atticus Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Atticus Pharma's shares on secondary markets.